Abstract: A method for distributing an equity reward for federated learning based on an equity theory includes the following steps: applying Adams' equity theory to federated learning, analyzing, by a participant, all factors invested in a federated task comprehensively, then giving an expected reward for this task, calculating, by the task publisher, the reputation of the participant; participating, by the participant, in each round of a training task using a local data to evaluate data contribution, model contribution, and a waiting-time allowance of the participant, then combining contribution results of the three factors to evaluate the contribution of the participant; after a global model converges, dynamically adjusting weights of the three factors according to an objective function of the equity reward, with a goal that an actual reward of the participant is as close as possible to the expected reward, and obtaining and distributing the actual reward of the participant.

Abstract: A method and a device for determining a picture with texts are provided. The method includes: acquiring an original picture for determining the picture with the texts; determining the quantity and/or position coordinate information of textboxes in the original picture based on the original picture and a textbox detection network; and determining whether the original picture is the picture with the texts based on the quantity and/or position coordinate information of the textboxes.

Abstract: A supercapacity lithium ion battery cathode material, a preparation method therefor and an application thereof. The supercapacity lithium ion battery cathode material consists of a transition metal-containing lithium ion cathode material and carbon which is coated on the surface of the lithium ion cathode material. The transition metal on the surface of the lithium ion cathode material is coordinated with carbon by means of X—C bonds to form transition metal-X—C chemical bonds, such that carbon stably coats the surface of the cathode material, wherein C is SP3 hybridization and/or SP2 hybridization, and X is at least one selected from among N, O and S.

Abstract: A supercapacity lithium ion battery cathode material, a preparation method therefor and an application thereof. The supercapacity lithium ion battery cathode material consists of a transition metal-containing lithium ion cathode material and carbon which is coated on the surface of the lithium ion cathode material. The transition metal on the surface of the lithium ion cathode material is coordinated with carbon by means of X—C bonds to form transition metal-X—C chemical bonds, such that carbon stably coats the surface of the cathode material, wherein C is SP3 hybridization and/or SP2 hybridization, and X is at least one selected from among N, O and S.

Abstract: The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of such compounds for the treatment of diseases related to dysfunction of vasodilation, inflammation, and/or endothelial cells. In particular non-limiting embodiments, components of the invention may be used to treat hypertension.

Abstract: The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of such compounds for the treatment of diseases related to dysfunction of vasodilation, inflammation, and/or endothelial cells. In particular non-limiting embodiments, components of the invention may be used to treat hypertension.

Abstract: The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of such compounds for the treatment of diseases related to dysfunction of vasodilation, inflammation, and/or endothelial cells. In particular non-limiting embodiments, components of the invention may be used to treat hypertension.

Abstract: The present invention relates to the field of human-machine interactions and discloses an information processing method and an electronic device so as to address the technical problems in the convention that it may be time-consuming for the electronic device to receive an entry operation and the electronic device may respond to an improper entry operation. The method is applicable to an electronic device with a display unit on which there are displayed N target objects, wherein N is a positive integer, there is a display parameter for each of the target objects, there is an initial value for the display parameter of each of the target objects, and the display parameter is configured to determine a display size of the target object, and wherein the method includes: determining M target objects and K target objects among the N target objects according to a preset rule.

Abstract: The present invention relates to compounds with activity as BACE1 and NF?B modulators, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease. The present invention is also directed to the treatment of diseases related to dysfunction of cell proliferation, the immune system and/or inflammation using such compounds or pharmaceutical compositions containing such candidate compounds.

Abstract: The present invention relates to compounds with activity as BACE1 and NF?B modulators, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease. The present invention is also directed to the treatment of diseases related to dysfunction of cell proliferation, the immune system and/or inflammation using such compounds or pharmaceutical compositions containing such candidate compounds.

Abstract: The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of such compounds for the treatment of diseases related to dysfunction of vasodilation, inflammation, and/or endothelial cells. In particular non-limiting embodiments, components of the invention may be used to treat hypertension.

Abstract: The present invention relates to compounds with activity as BACE1 and NF?B modulators, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease. The present invention is also directed to the treatment of diseases related to dysfunction of cell proliferation, the immune system and/or inflammation using such compounds or pharmaceutical compositions containing such candidate compounds.

Abstract: The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of such compounds for the treatment of diseases related to dysfunction of vasodilation, inflammation, and/or endothelial cells. In particular non-limiting embodiments, components of the invention may be used to treat hypertension.

Abstract: The present invention relates to compounds with activity as inhibitors of sAPP? and A? production, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease and pharmaceutical compositions containing such candidate compounds.